Effect of intravitreal injection of dexamethasone implant on corneal endothelium in macular edema due to retinal vein occlusion.
Autor: | Ilhan N; a Department of Ophthalmology , Medical Faculty of the Mustafa Kemal University , Hatay , Turkey and., Coskun M; a Department of Ophthalmology , Medical Faculty of the Mustafa Kemal University , Hatay , Turkey and., Ilhan O; a Department of Ophthalmology , Medical Faculty of the Mustafa Kemal University , Hatay , Turkey and., Ayhan Tuzcu E; a Department of Ophthalmology , Medical Faculty of the Mustafa Kemal University , Hatay , Turkey and., Daglıoglu MC; a Department of Ophthalmology , Medical Faculty of the Mustafa Kemal University , Hatay , Turkey and., Elbeyli A; b Department of Ophthalmology , Antakya State Hospital , Hatay , Turkey., Keskin U; a Department of Ophthalmology , Medical Faculty of the Mustafa Kemal University , Hatay , Turkey and., Oksuz H; a Department of Ophthalmology , Medical Faculty of the Mustafa Kemal University , Hatay , Turkey and. |
---|---|
Jazyk: | angličtina |
Zdroj: | Cutaneous and ocular toxicology [Cutan Ocul Toxicol] 2015; Vol. 34 (4), pp. 294-7. Date of Electronic Publication: 2014 Oct 27. |
DOI: | 10.3109/15569527.2014.975242 |
Abstrakt: | Objective: To evaluate the effects of dexamethasone (DEX) implant (Ozurdex(®)) on corneal endothelium in patients with retinal vein occlusion complicated with macular edema. Materials and Methods: Patients (n = 31) received 1-3 intravitreal DEX implants in one eye. Measurements were intraocular pressure (IOP) at baseline and 1, 3, and 6 months after the first intravitreal injection and corneal specular microscopy and central corneal thickness (CCT) at baseline and 1 and 6 months. We analyzed endothelial cell density (ECD), coefficient of variation of cell size (CV), and percentage of hexagonality. Results: Mean follow-up period was 9.7 ± 3.3 months. Mean number of injections was 1.5 ± 0.8. Mean IOP values were 15.6 ± 2.6 mm Hg at baseline, 17.7 ± 3.6 mm Hg at one month, 16.4 ± 4.1 mm Hg at three months, and 16.0 ± 2.7 mm Hg at six months. There was a significant difference in mean IOPs at one month and six months (p = 0.008). There were no significant differences in mean ECD (p = 0.375), CV (p = 0.661), percentage of hexagonality (p = 0.287), and CCT (p = 0.331). Conclusion: Although intravitreal injection of 0.7 mg DEX causes moderate elevation of IOP, it does not seem to have detrimental effects on corneal endothelium at six months. |
Databáze: | MEDLINE |
Externí odkaz: |